New injection aims to boost immune systems in HIV patients
NCT ID NCT07443228
Summary
This early-stage study is testing an experimental injection called JL18008 in people living with HIV. It's designed for patients whose immune systems remain weak despite taking effective antiviral medications. The research will first check if the injection is safe, then see if it can help increase important immune cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.